How Monday works

How we turn sources into useful summaries.

See how we review peptide records, describe the evidence, and build a research brief from your answers.

Linked sourcesDated reviewsClear evidence limits

What goes into an Atlas entry

Each entry identifies the compound, its common names, and its molecular form. It includes a research summary, source links, and details to check before comparing it with another compound.

The Atlas grows as we review more sources. It is not a complete catalog of research. Related small molecules, proteins, and mixtures are identified separately from peptides.

What the evidence labels mean

Evidence labels describe the kind of research available. They do not rate a compound's safety or effectiveness. Studies within the same group can differ in quality, and findings apply to the exact form and setting studied.

ES

Established

A defined medicine has a regulated use and substantial human research. Check the exact product, approved use, and label.

CL

Clinical

The compound has been studied in people. The studies may still be small, early, or limited to a narrow question.

EM

Emerging

Research is early, limited, or mixed. Read each study to understand its setting and what it measured.

PR

Preclinical

Most of the research is in cells, animals, or other laboratory settings. It does not establish an outcome in people.

Use the label to find your bearings, then read the linked studies and regulatory records for the details.

How your research brief is built

Choose a peptide and answer five questions about your research. The builder uses those answers to suggest a focus and three next steps. It does not ask for health details, doses, or confidential project information.

Research Brief inputs
InputYour answerHow it helpsLimits
00PeptideA compound in the AtlasAdds its summary and identity questionsEvidence stays specific to the exact form
01Research settingIndependent, academic, commercial, educational, or procurementAdds context to the saved briefDoes not change access or source-link eligibility
02Research taskIdentity, handling, methods, literature, or general researchFocuses the next steps on your taskDoes not validate a method or result
03Main questionCOA, identity, batch records, handling, or availabilitySets the first question to investigateDoes not verify the information selected
04Research stageLearning, comparing, planning, sourcing, or recurring workAdjusts questions about timing and repeat workDoes not create a deadline
05Requested resourceBrief, documentation, source directory, availability, or allShapes the optional email follow-upDoes not change the on-page brief

Your task, main question, and timing guide the result. The same answers produce the same brief.

Read your brief before choosing email

Your complete brief appears on the page. Email delivery is optional. If a follow-up includes a commercial relationship, we disclose it before the related link.

Equal access

Your research setting does not change your brief, account access, or eligibility for an optional source link.

Optional source links depend on the resources you request and your research timing. We do not send email addresses to advertising analytics.

Where the tools stop

  • Molecular identity.An Atlas entry or a COA field cannot prove the identity of material you receive.
  • Quality or quantity.A purity percentage alone does not establish quantity, authenticity, sterility, or suitability.
  • Scientific validity.An evidence label or research brief does not validate a study, method, or conclusion.
  • Safety or suitability.Monday is an educational research reference, not medical, veterinary, legal, or professional advice.
  • Source performance.A source link does not mean Monday has certified the supplier or material.
ContinueRead the peptide evidence guide

Take a closer look at a peptide.

Read its summary, check the exact molecular form, and open the sources behind it.

Explore peptides